Clinical Trials Directory

Trials / Completed

CompletedNCT06193109

The Prognostic Impact of Right Ventricular Systolic Dysfunction on the Survival of Patients With Sepsis and Septic Shock

Status
Completed
Phase
Study type
Observational
Enrollment
200 (actual)
Sponsor
Burapha University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study sought to evaluate the association of right ventricular systolic dysfunction and 28-day in-hospital mortality in patients with sepsis and septic shock. Prospective cohort study of adult patients admitted at Burapha university hospital from October 1, 2022 through June 30, 2023 for sepsis and septic shock, who had an echocardiogram within 72 hours after admission for evaluating right ventricular systolic function. Right ventricular systolic dysfunction was defned by the American Society of Echocardiography criteria. Outcomes included 28-day in-hospital mortality, maximal blood lactate, length of intensive care unit(ICU) stay and duration of mechanical ventilation.

Conditions

Interventions

TypeNameDescription
OTHERthe patients with sepsis and septic shock were performed echocardiography for detecting right ventricular systolic function

Timeline

Start date
2022-10-01
Primary completion
2023-06-30
Completion
2023-07-30
First posted
2024-01-05
Last updated
2024-01-05

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT06193109. Inclusion in this directory is not an endorsement.

The Prognostic Impact of Right Ventricular Systolic Dysfunction on the Survival of Patients With Sepsis and Septic Shock (NCT06193109) · Clinical Trials Directory